Clinical trial retention starts before randomization

A 2024 analysis of nearly 800 trials found that the harder a consent form was to read, the more patients dropped out. The decision to stay is often made long before randomization. Here is what that means for how studies recruit.

June is Men’s Health Week

The pattern is well documented. Men are more likely to skip routine screenings, delay care, and stay silent about symptoms until they become serious…

Investing in Our Team at 1nHealth

Investing in our team is a direct investment in the sponsors and patients we serve. We will keep building the skills that make every partnership stronger.

The gap between Alzheimer’s research and the people who need it most

For Dan, CEO and founder of 1nHealth, Alzheimer’s disease is not a therapeutic area on a strategy deck. He lost his grandmother to it. That loss is part of why he built this company, and part of why closing the distance between Alzheimer’s research and the communities it was designed to serve sits at the center of what 1nHealth does.

The dropout problem in antidepressant research is a recruitment problem.

When a psychiatric drug trial struggles to keep participants enrolled, the conversation usually turns to the sites. Site staff get asked to follow up more often, schedule more carefully, and chase harder.
But the data points somewhere else. The pattern that drives dropout in antidepressant research begins well before a patient ever walks into a site. It begins at recruitment.